Arkolith/Insider Trading/PRVB/Form 4

Palmer Ashleigh

Director and CEO, DirectorProvention Bio, Inc. (PRVB) · full profile →Form 4 · filed Feb 14, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$765K
Net Open-Market Flow
-$765K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 13, 2023Option exercise(M)26K$2.50$65K2.6M
Feb 13, 2023Sell(S)26K$10.04$259K2.6M
Feb 10, 2023Option exercise(M)50K$2.50$125K2.6M
Feb 10, 2023Sell(S)50K$10.11$506K2.6M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 13, 2023Option exercise(M)26K—$0442K
Feb 10, 2023Option exercise(M)50K—$0468K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-005076) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML